• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

Keryx Biopharmaceuticals - Articles and news items


EC approves Fexeric for the treatment of hyperphosphatemia

Industry news / 24 September 2015 / Victoria White

Fexeric is approved for the control of elevated serum phosphorus levels in adults with chronic kidney disease, including both dialysis and pre-dialysis patients…


Keryx’s hyperphosphatemia treatment Fexeric backed for European approval

Industry news / 24 July 2015 / Victoria White

The CHMP has adopted a positive opinion for on marketing authorisation of Fexeric, recommending its approval for the treatment of hyperphosphatemia in CKD…


Webinar: Use of MicroNIR to optimise fluid bed drying and to reduce waste at tablet compressionFIND OUT MORE
+ +